No photo of Robin L Polt

View Scopus Profile

Robin L Polt

  • 2888 Citations
  • 29 h-Index
1982 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Robin L Polt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

PACAP/VIP Glycopeptide Agonists as Neuroprotective Therapies for Parkinson's Disease

Polt, R. L.

National Institutes of Health

9/30/15 → 6/30/20

Project: Research project

    • ALKYLBERYLLIUMS: STEREOCONTROLLED ADDITIONS OF CARBONYL

    Polt, R. L.

    National Institutes of Health

    8/19/87 → …

    Project: Research project

    BIOUSIAN GLYCONEUROPEPTIDE AMPHIPATHS PENETRATE THE BBB

    Polt, R. L.

    National Institutes of Health

    4/10/07 → 3/31/13

    Project: Research project

    • Research Output

    • 2888 Citations
    • 29 h-Index
    • 75 Article
    • 4 Review article
    • 1 Comment/debate
    • 1 Editorial

    Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration

    Stevenson, G. W., Giuvelis, D., Cormier, J., Cone, K., Atherton, P., Krivitsky, R., Warner, E., St. Laurent, B., Dutra, J., Bidlack, J. M., Szabò, L., Polt, R. & Bilsky, E. J., Apr 1 2020, In : Psychopharmacology. 237, 4, p. 1195-1208 14 p.

    Research output: Contribution to journal › Article

    Highly-selective μ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model

    Bartlett, M. J., So, L. Y., Szabò, L., Skinner, D. P., Parent, K. L., Heien, M. L., Vanderah, T. W., Polt, R., Sherman, S. J. & Falk, T., Mar 12 2020, In : BMC research notes. 13, 1, 149.

    Research output: Contribution to journal › Article

    Open Access

    • In silico Docking Studies of Fingolimod and S1P1 Agonists

    Marciniak, A., Camp, S. M., Garcia, J. G. N. & Polt, R., Mar 10 2020, In : Frontiers in Pharmacology. 11, 247.

    Research output: Contribution to journal › Article

    Open Access

    • Sphingosine-1-phosphate receptor-independent lung endothelial cell barrier disruption induced by FTY720 regioisomers

    Camp, S. M., Marciniak, A., Chiang, E. T., Garcia, A. N., Bittman, R., Polt, R., Perez, R. G., Dudek, S. M. & Garcia, J. G. N., Jan 1 2020, In : Pulmonary Circulation. 10, 1

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    A novel angiotensin-(1-7) glycosylated MAs receptor agonist for treating vascular cognitive impairment and inflammation-related memory dysfunction

    Hay, M., Polt, R., Heien, M. L., Vanderah, T. W., Largent-Milnes, T. M., Rodgers, K., Falk, T., Bartlett, M. J., Doyle, K. P. & Konhilas, J. P., Apr 2019, In : Journal of Pharmacology and Experimental Therapeutics. 369, 1, p. 9-25 17 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations